Table 1.

EXODIAG study inclusion and exclusion criteria for cancer patients

Inclusion criteria for cancer patients

Women newly diagnosed with infiltrating non-metastatic breast cancer (positive or negative HER status or hormone therapy).  Women with breast cancer with a first metastatic evolution (positive or negative HER status or hormone therapy).

Women newly diagnosed with stage III and ICV ovarian cancer.  Men and women newly diagnosed with metastatic non-small cell lung cancer.

Patients older than 18 years.  Performance status of 0 or 1 at the time of inclusion, according to the Eastern Cooperative Oncology Group (ECOG) and WHO.

Affiliated to the French social security social or beneficiary of such a regimen.

Written informed consent.

Exclusion criteria for cancer patients

Patient with another synchronous tumour.

Men with breast cancer.

Positive serology for HIV, HCV or HBV.

Patients unable to undergo medical follow-up for geographical, social or psychological reasons.

Pregnant or nursing women.